Monthly Industry Insights
Life Sciences edition: How localisation is shaping healthcare March, 2025
In today’s highly connected world, the life healthcare industry is experiencing a significant transformation driven by localisation. From clinical trials to patient education and regulatory compliance, the ability to effectively communicate across languages and cultures is becoming a critical factor in delivering high-quality healthcare services. Here’s how localisation is shaping the future of healthcare.
1. Enhancing patient-centred care
Language barriers can be a major obstacle to effective healthcare delivery. Localisation ensures that patient materials, consent forms, and medical information are accurately translated and culturally adapted to improve comprehension. This not only enhances patient experience but also reduces risks associated with miscommunication.
2. Driving success in clinical trials
Clinical trials are essential for bringing new treatments to market, yet their success hinges on patient recruitment and regulatory approval across different regions. By localising trial documentation, including informed consent forms and study protocols, organisations can boost participant engagement and meet regulatory requirements in various countries.
3. Supporting Regulatory Compliance
Healthcare regulations differ significantly from one country to another. Proper localisation of documentation ensures compliance with local laws, reducing the risk of costly delays or rejections. Whether it’s pharmaceutical labelling, medical device instructions, or electronic health records, precise translation and adaptation are crucial.
4. Advancing medical training and e-learning
Healthcare professionals must continually update their knowledge to keep up with industry advancements. Localising e-learning courses, training modules, and medical education materials allows professionals worldwide to access high-quality training in their native language, ultimately improving healthcare standards.
5. Strengthening market access for Life Science companies
For pharmaceutical and medical device companies looking to expand globally, localisation plays a vital role in market penetration. Adapting marketing materials, packaging, and user instructions to different linguistic and cultural contexts increases product acceptance and fosters trust among healthcare providers and patients alike.
Partner with experts in localisation
At Dialecta, we specialise in helping healthcare and life sciences organisations navigate the complexities of multilingual communication. Our expert team ensures that translations are not only accurate but also culturally sensitive and industry-compliant. Whether you need localisation for clinical research, patient communication, or regulatory documents, we are here to support your global success.
Interested in learning how localisation can benefit your healthcare business? Contact us today to explore tailored solutions that meet your needs.
Stay tuned for more industry insights in our next edition!
REFERENCE LIST:
- Al Shamsi H, Almutairi AG, Al Mashrafi S, Al Kalbani T. Implications of Language Barriers for Healthcare: A Systematic Review. Oman Med J. 2020 Apr 30;35(2):e122.
- Krogstad DJ, Diop S, Diallo A, Mzayek F, Keating J, Koita OA, Touré YT. Informed consent in international research: the rationale for different approaches. Am J Trop Med Hyg. 2010 Oct;83(4):743-7.
- Aryee, G.F.B., Amoadu, M., Obeng, P. et al. Effectiveness of eLearning programme for capacity building of healthcare professionals: a systematic review. Hum Resour Health 22, 60 (2024).
- Elliott SA, Bialy L, Scott SD, Hartling L. Exploring methods for creating or adapting knowledge mobilization products for culturally and linguistically diverse audiences: a scoping review. Arch Public Health. 2024 Jul 22;82(1):111.